Clinical Trials
75 trialsShared Decision Making in Low Risk Prostate Cancer
Massachusetts General Hospital
TA-P-OLIM
University Hospital, Ghent
Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
CHEMOPROST
Institut Bergonié
Determination of Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict GI Radiation Toxicity
DiaCarta, Inc.
iConquerFear Program for the Treatment of Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma
City of Hope Medical Center
A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer
Pfizer
PROCeed-BR
AstraZeneca
A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer
Johnson & Johnson Private Limited
TOGETHER
Janssen Research & Development, LLC
Dynamic Whole Body PET/ MRI
British Columbia Cancer Agency
Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis
Sir Mortimer B. Davis - Jewish General Hospital
The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient
Sir Mortimer B. Davis - Jewish General Hospital
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
LEPTO
RECORDATI GROUP
VS-UrineID
University of Kansas Medical Center
Clinical Performance Evaluation of the C2i Test
University of Texas Southwestern Medical Center
Impact of Perioperative Anesthetic Management on Renal Cancer Progression.
M.D. Anderson Cancer Center
Longitudinal Geriatric Assessment to Optimize Outcomes of Older Patients With Muscle-Invasive Bladder Cancer After Radical Cystectomy
University of Kansas Medical Center
Focal Therapy for Localized Prostate Cancer
China Medical University Hospital
Investigation of Protein Biomarkers of Prostate Cancer
University of New Mexico
Identification of Risk Allels for Prostate Cancer
University of New Mexico
Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC
HKGepitherapeutics
Micro-RNA Expression Profiles in Localised Prostate Cancer
Wuerzburg University Hospital
New Markers for Treatment Response to Radiotherapy in Prostate Cancer
University of Basel
Axitinib Therapy Management Study
Pfizer
GBCPRT0008
Global BioClinical
Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer
University of California, Irvine
Platelet-lymphocyte and Neutrophil-lymphocyte Ratio in Patients Undergoing Cancer Surgery
Medipol University
Mapping 3D Bladder
University Health Network, Toronto
Spermine Measuring Device Evaluation Protocol
Chinese University of Hong Kong
CAMPAS
Omnitura Therapeutics, Inc.
Relationship Between Circulating Tumor Cell Cultures' Treatment Response and Clinical Outcomes
UNC Lineberger Comprehensive Cancer Center
Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly
Rutgers, The State University of New Jersey
Tissue Collection to ID TCRs From Renal Clear Cell Carcinoma Patients Responding to Immune Checkpoint Inhibitors
TScan Therapeutics, Inc.
Electromagnetic Tracking of Devices During Interventional Procedures - A Cryoablation Study
Philips Healthcare
Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer
IsoRay Medical, Inc.
CAROLINE
Ipsen
Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer
University of Southern California
Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate
National Cheng-Kung University Hospital
The Impact of Ureteral Stents on Peristalsis
University of British Columbia
GCC 1261
University of Maryland, Baltimore
Quantification of Respiratory-induced Prostate Motion
Oregon Health and Science University
An Exploratory Correlative Study of Biomarkers in Patients With Metastatic Renal Cell Carcinoma Who Have Progressed After Sunitinib Therapy
British Columbia Cancer Agency
Study of Muscle Energy Metabolism in RCC Patients Treated With Sunitinib
AHS Cancer Control Alberta
A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies
Stanford University
VPCA-B+PIV
Celsee Diagnostics
PD-1 Knockout Engineered T Cells for Castration Resistant Prostate Cancer
Peking University
Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With Ketoconazole
Alliance for Clinical Trials in Oncology
PRX32
University of Florida